SEC Sues Invitrogen Scientist For Insider Trading
The U.S. Securities and Exchange Commission sued a former scientist at bioteceh company Invitrogen Corp. on Tuesday for allegedly engaging in insider trading based on information he obtained at company meetings....To view the full article, register now.
Already a subscriber? Click here to view full article